Virus cocktail takes on superbug UTIs in tiny new trial
NCT ID NCT07382271
First seen Feb 02, 2026 · Last updated Jun 22, 2026 · Updated 21 times
Summary
This early study tests whether a personalized mix of viruses (called phages) can safely treat urinary tract infections caused by drug-resistant bacteria. Six adults aged 18–65 will receive the phage cocktail through a catheter every 12 hours for 2–3 days. Researchers will monitor side effects, how well the bacteria are cleared, and whether symptoms improve over 2–4 weeks of follow-up.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
personalized phage cocktail (viruses that kill specific bacteria)
What this could lead to
If it works, this could point toward a new treatment option for people with stubborn urinary tract infections that don't respond to antibiotics.
What could go wrong
This is a very early, tiny study with only 6 people, so results may not apply broadly. Phage therapy can cause allergic reactions or fail to clear the infection.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.